Show notes
A.I. , Synthetic Biology, Discovering Protein compounds, LabGenius, and Developing EVA an AI Evolution Engine for Discovering Protein Components.
James and I talked about his inspiration, the key points that changed his life, how he developed the company, how to best make use of your team, how to notice and find the right type of investors, and much, much more. James is the CEO and founder of LabGenius where he combines A.I. with synthetic biology in a unique and interesting way. We get into all of this in the podcast.
What LabGenius has built
"LabGenius has developed EVA - an autonomous AI-driven evolution engine for the discovery of high-value protein components. The company uses its platform technology to develop new products in partnership with world-leading multinationals. LabGenius is based in Central London and run by a passionate team of synthetic biologists, data scientists and engineers. " Source
About James
"James completed his EPSRC-funded PhD at Imperial College London where he developed a platform for targeted drug delivery using re-engineered protein nanocages. Prior to his PhD, James completed a BS in Biology with Microbiology (1st Class) and an MRes in Systems and Synthetic Biology (Distinction), at Imperial College London.
James is an active member of the synthetic biology community having participated in the iGEM competition both as an undergraduate (2009), advisor (2011) and judge (2016).
In 2017, James was awarded the BBSRC Innovator of the Year award for early career impact. In 2018, James was featured on Forbes' 30 Under 30 list for Science & Healthcare. James is also a fellow of the prestigious Synthetic Biology Leadership Excellence Accelerator Program (LEAP).
Outside of work, James enjoys time with his daughter, reading science fiction, and drinking loose leaf Earl Grey tea." Source
Hyperlinked Timestamped Show Notes (only clickable on this website):
* [
* [
* [
* [
* [
* [
* [
* [
* [
* [
* [
* [
* [

